Zura Bio
Kiran Nistala is currently the Chief Medical Officer at Zura Bio Limited. Prior to this role, Kiran worked as a Clinical Development Consultant at Sunray Consultancy Ltd. and as the Vice President Clinical Immunology at AstraZeneca. Kiran has also held various positions at GSK, including MRC EMINENT Scientific Coordination Committee, Discovery Medicine Group Leader, and Co-chair Immunotoxicology Panel. Kiran's early career includes roles at Great Ormond Street Hospital for Children NHS Foundation Trust and Wellcome Trust. Kiran holds a PhD in Immunology from UCL and has completed a postgraduate certificate in Executive Relational Coaching from Hult Ashridge.
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.